Nov 26, 2014 09:20
9 yrs ago
2 viewers *
English term
C1D-2
English to Russian
Medical
Genetics
Критерии включения/исключения клинического исследования
http://www.cancer.gov/clinicaltrials/search/view?cdrid=76224...
Exclusion Criteria:
• Received anticancer agent(s) or an investigational agent within 21 days prior to C1D-2 or radiotherapy within 28 days prior to C1D-2.
• Prior treatment with palliative local breast or bone lesion radiation (other than pelvis) can occur, if administered at least 14 days prior to C1D-2.
• Anticancer hormonal therapy must be stopped 7 days before starting C1D-2.
Я понимаю, что «C1D-2» переводить не надо, но в русском переводе принято называть сам процесс - что это: анализ гена C1D-2?
Exclusion Criteria:
• Received anticancer agent(s) or an investigational agent within 21 days prior to C1D-2 or radiotherapy within 28 days prior to C1D-2.
• Prior treatment with palliative local breast or bone lesion radiation (other than pelvis) can occur, if administered at least 14 days prior to C1D-2.
• Anticancer hormonal therapy must be stopped 7 days before starting C1D-2.
Я понимаю, что «C1D-2» переводить не надо, но в русском переводе принято называть сам процесс - что это: анализ гена C1D-2?
Proposed translations
(Russian)
| 5 | Ц1Д-2 |
Natalie
|
| 4 | 2-й день 1-го цикла |
Alieksei Seniukovich
|
Proposed translations
2 hrs
Selected
Ц1Д-2
"Ц1Д-2" означает "за 2 дня до Д1Ц1", т.е. за 2 дня до первого дня первого цикла основной терапии
4 KudoZ points awarded for this answer.
Comment: "Спасибо!"
5 mins
Alieksei Seniukovich
Poland
Poland
Native in Russian
Works in field
Poland
'Medical Linguistics Professional'
Native in: Russian (Variant: Standard-Russia) 
Works in: English to Russian, Russian to English, English to Belarusian, and 3 more.
Related KudoZ points
:
8
2-й день 1-го цикла
!
--------------------------------------------------
Note added at 6 mins (2014-11-26 09:26:12 GMT)
--------------------------------------------------
C1D2 — cycle 1 day 2.
Relative changes (mean and standard deviation) in γ-H2AX expression in CD3+ (A) and CD14+ (B) cells and by microscopy (C) before and after treatment. Figure S2C shows representative images of γ-H2AX foci incidence in PBMCs from one patient pre-treatment (C1D1), cycle 1 day 2 (C1D2), cycle 1 day 3 (C1D3), and cycle 2 day 1 pre-treatment (C2D1). Green, γ-H2AX; red, DNA stained with propidium iodide
--------------------------------------------------
Note added at 6 mins (2014-11-26 09:26:12 GMT)
--------------------------------------------------
C1D2 — cycle 1 day 2.
Relative changes (mean and standard deviation) in γ-H2AX expression in CD3+ (A) and CD14+ (B) cells and by microscopy (C) before and after treatment. Figure S2C shows representative images of γ-H2AX foci incidence in PBMCs from one patient pre-treatment (C1D1), cycle 1 day 2 (C1D2), cycle 1 day 3 (C1D3), and cycle 2 day 1 pre-treatment (C2D1). Green, γ-H2AX; red, DNA stained with propidium iodide
Something went wrong...